NNIT A/S NNIT

NNIT AS (OCSE:NNIT) navigates a challenging quarter with strong margin recovery in the U.S. and robust Public Denmark growth, while advancing its AI platforms and strategic transformation.

Q2 2026 key highlights NNIT's financial performance was in line with initial expectations, despite continued customer caution, particularly within the life science segments. However, order entry improved during the quarter across all regions, supported by targeted growth initiatives aimed at strengthening sales execution. Reported group revenue declined 4.5% to DKK 441.6m, corresponding to constant currency revenue growth of -4.4%. The decline was primarily driven by the life science regions, wh

NNIT AS (STU:5NN) faces revenue declines but remains optimistic with new AI platforms and strategic initiatives to drive future growth.

May 7, 2026 NNIT UPDATES 2026 OUTLOOK AND RELEASES PRELIMINARY FINANCIAL FIGURES FOR Q1 2026 NNIT’s financial performance and order entry were below initial expectations in Q1 2026, reflecting continued geopolitical turmoil and sustained customer caution, particularly within the Life Science IT consulting industry. NNIT updates the 2026 outlook and now expects constant currency revenue growth to be single-digit negative (previously 0 to 5%) and the group EBIT margin excl. special items to come t

Today, NNIT announces an update to its financial disclosure (cf. company announcement 02/2026) to align terminology with peers and provide more transparency into the financial development of Public DK and SCALES. Terminology changeSince 2023, NNIT has reported separately on “revenue growth” and “organic growth”. These terms will now be changed to “reported revenue growth” and “constant currency revenue growth”. “Organic growth” will be re-introduced if M&A activity is completed. For practical pu

NNIT A/S today announces that Claus Rydkjær has been appointed Chief Executive Officer, joining the company as of April 7, 2026. Claus Rydkjær will succeed Pär Fors, who in January announced his decision to step down after almost five years in the role. Chairman of the Board Carsten Dilling comments:“NNIT is entering an important next phase of executing our strategy with a strong focus on growing our footprint in life sciences internationally and the public sector in Denmark. Claus brings more t